Balloon Angioplasty News and Research

RSS

Balloon Angioplasty is a procedure to enlarge the opening in a blood vessel that has become narrowed or blocked by plaque (a buildup of fat and cholesterol on the inner wall of the blood vessel). A small balloon is filled with air inside the blood vessel to push the plaque against the blood vessel wall and increase the opening.

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.

27 Jun 2011

Angioplasty may be an option for liver transplant candidates with heart disease

A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD). Details of the study are available in the July issue of Liver Transplantation, published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

22 Jun 2011

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

22 Jun 2011

Only 10% of patients with heart attack transferred to another hospital for PCI in recommended time

Only about 10 percent of patients with a certain type of heart attack who need to be transferred to another hospital for a PCI are transferred within the recommended time of 30 minutes, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

Boston Scientific to launch Mustang PTA Balloon Catheter worldwide

Boston Scientific Corporation today announced the global launch of its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. The Company plans to launch the product immediately in the U.S., Europe and other international markets.

20 Jun 2011

Patients still being enrolled in clinical trial for new peripheral vascular disease treatment

The first three patients to undergo an investigational surgical procedure for peripheral vascular disease that involves the patient's own stem cells continue to do well, reports the University of Louisville surgeon who is the principal investigator.

18 Jun 2011

New drug more effective than standard treatment to prevent heart-attack deaths

Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented if a new drug, ticagrelor, was used instead of the standard treatment, clopidogrel.

13 Jun 2011

Ambulance diversion linked to high risk of mortality in patients with acute myocardial infarction

Among Medicare patients with heart attack in 4 California counties, diversion of ambulance traffic by the nearest emergency department for 12 hours or more was associated with an increased risk of death for up to one year, according to a study in the June 15 issue of JAMA.

13 Jun 2011

IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease

IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.

3 Jun 2011

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. today announced recent milestones in its clinical program for the IN.PACT drug-eluting balloon technology.

From Medtronic 17 May 2011

MEDRAD's Cotavance catheter with Paccocath technology receives European CE Mark approval

MEDRAD, INC., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocath technology.

17 May 2011

ESC calls for single co-ordinated European system to oversee evaluation, approval of medical devices

The European Society of Cardiology (ESC) is calling for a single, co-ordinated European system to oversee the evaluation and approval of medical devices. The call is being made in a paper published online in the European Heart Journal reporting on a conference held by the ESC in January 2011 looking to increase the input of medical experts in developing medical device policy.

17 May 2011

Stenting is safe, effective and superior to balloon angioplasty for deep vein thrombosis treatment

Stenting is safe and effective and superior to balloon angioplasty for treatment of venous stenosis in patients with deep vein thrombosis, according to results from EVISTA-DVT, presented today as a Late-Breaking Clinical Trial at the Society for Cardiovascular Angiography and Interventions 2011 Scientific Sessions in Baltimore.

7 May 2011

Coronary artery bypass graft surgeries have declined by 30% between 2001 and 2008

Between 2001 and 2008, the annual rate of coronary artery bypass graft surgeries performed in the United States decreased by more than 30 percent, but rates of percutaneous coronary interventions did not change significantly, according to a study in the May 4 issue of JAMA.

4 May 2011

Heart bypass surgery rates fall by 38% between 2001 and 2008: Study

According to latest the U.S. research, the number of heart patients getting bypass surgery fell by 38 percent between 2001 and 2008. This fall reflects several factors, including a decline in smoking rates, which has led to less coronary artery disease, said senior study author Dr. Peter Groeneveld, an assistant professor of medicine at the University of Pennsylvania School of Medicine.

4 May 2011

Study finds increase in implementation of evidence-based therapies for myocardial infarction

In an analysis of data from a coronary care registry in Sweden, between 1996-2007 there was an increase in the prevalence of use of evidence-based invasive procedures and pharmacological therapies for treatment of a certain type of heart attack, and a decrease in the rate of death at 30 days and one year after a heart attack for these patients, according to a study in the April 27 issue of JAMA.

28 Apr 2011

Vascular Center at Mercy installs Toshiba Infinix VC-i and customized CAT-880B catheterization table

Enhancing diagnostic and interventional capabilities to provide the highest level of patient care, The Vascular Center at Mercy Medical Center, Baltimore has installed the InfinixTM VC-i and customized CAT-880B catheterization table from Toshiba America Medical Systems, Inc. for its new state-of-the-art hybrid operating room (OR).

28 Apr 2011

Loyola's HARRT program enhances emergency angioplasty times

The availability of an in-house, around-the-clock interventional cardiology team dramatically decreases the time it takes to restore blood flow to heart attack patients, according to data presented this week.

8 Apr 2011

New data finds 50% decline in heart surgery wait times in Alberta and BC

New data from the University of Calgary's Faculty of Medicine shows that wait times for a number of heart surgeries have gone down close to 50 per cent in Alberta and British Columbia.

6 Apr 2011

Improved technology is improving outcomes for cardiac stent patients

While coronary artery bypass surgery has long been the standard treatment for patients with the most extensive forms of coronary artery disease, the results of a recent study by an international team of researchers suggests that advances in technology appear to be narrowing the "benefit gap" between the two approaches. The results of the study appear in the March 17, 2011 issue of the New England Journal of Medicine.

28 Mar 2011

Balloon Angioplasty News and Research

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Angioplasty may be an option for liver transplant candidates with heart disease

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

Only 10% of patients with heart attack transferred to another hospital for PCI in recommended time

Boston Scientific to launch Mustang PTA Balloon Catheter worldwide

Patients still being enrolled in clinical trial for new peripheral vascular disease treatment

New drug more effective than standard treatment to prevent heart-attack deaths

Ambulance diversion linked to high risk of mortality in patients with acute myocardial infarction

IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

MEDRAD's Cotavance catheter with Paccocath technology receives European CE Mark approval

ESC calls for single co-ordinated European system to oversee evaluation, approval of medical devices

Stenting is safe, effective and superior to balloon angioplasty for deep vein thrombosis treatment

Coronary artery bypass graft surgeries have declined by 30% between 2001 and 2008

Heart bypass surgery rates fall by 38% between 2001 and 2008: Study

Study finds increase in implementation of evidence-based therapies for myocardial infarction

Vascular Center at Mercy installs Toshiba Infinix VC-i and customized CAT-880B catheterization table

Loyola's HARRT program enhances emergency angioplasty times

New data finds 50% decline in heart surgery wait times in Alberta and BC

Improved technology is improving outcomes for cardiac stent patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News